Clinical Trial Update: A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A

View source ↗

Summary

This is a clinical trial update for a study evaluating the impact of efanesoctocog alfa on long-term joint health in participants with Hemophilia A; the trial i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Efanesoctocog alfa (efanesoctocog alfa)

Snippet

Sponsor: Sanofi | Conditions: Hemophilia A | Status: ACTIVE_NOT_RECRUITING